Search Reports - Precedence Research

September 2026

Non-Hodgkin's Lymphoma Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

Report Code : 8414
Published : September 2026
Delivery : Immediate
Category : Healthcare
No. of Pages : 150+

The non-hodgkin's lymphoma market size reached USD 15.00 billion in 2026, with leading non-hodgkin's lymphoma market companies including Roche, Bristol Myers Squibb, Novartis, Gilead Sciences, Eli Lilly and Co.

January 2025

Non-Hodgkin's Lymphoma Therapeutics Market Size, Share and Trends 2025 to 2034

Report Code : 5497
Published : January 2025
Delivery : Immediate
Category : Healthcare
No. of Pages : 150+

The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 10.99 billion in 2025, with a CAGR of 7.43%.

June 2026

Follicular Lymphoma Market Size, Share and Trends 2026 to 2035

Report Code : 7151
Published : June 2026
Delivery : Immediate
Category : Healthcare
No. of Pages : 150+

The global follicular lymphoma market size is evaluated at USD 1.90 billion in 2025 and is predicted to hit around USD 2.74 billion by 2035, growing at a CAGR of 3.73%.

June 2026

Lymphoma Treatment Market Size, Share and Trends 2026 to 2035

Report Code : 6778
Published : June 2026
Delivery : Immediate
Category : Healthcare
No. of Pages : 150+

The global lymphoma treatment market size was evaluated at USD 8.08 billion in 2025 and is predicted to hit around USD 17.81 billion by 2035, growing at a CAGR of 8.22%.

July 2025

B-Cell Lymphoma Market Expands with Targeted Therapy Innovations

Report Code : 6471
Published : July 2025
Delivery : Immediate
Category : Healthcare
No. of Pages : 150+

The global B-cell lymphoma market size was evaluated at USD 5.08 billion in 2024 and is predicted to hit around USD 10 billion by 2034, growing at a CAGR of 7.00%.